Researchers and guideline contributors updated the American Academy of Pediatrics guidance from 2011 for infants and young children with suspected urinary tract infections. The guidance is intended for children with low medical complexity in a range of clinical settings and is supported by three technical reports describing the evidence and diagnostic criteria.
New guideline updates urinary infection guidance for children ages 8 days to 5 years
The American Academy of Pediatrics guideline covers diagnosis, antibiotics, imaging, and related evaluations, but notes limited certainty for its clinical recommendations.

What the review examined
The work examined the available research on diagnosing and managing urinary tract infections in children 8 days to 5 years old. It used the GRADE approach to assess how certain the evidence was and to develop recommendations and good-practice statements. The guideline includes eight key action statements—two strong and six conditional—as well as four good-practice statements. The abstract does not report a new patient sample size or describe this work as a randomized trial, cohort study, or other single clinical study.
What the review concluded
The guideline addresses medical evaluation of suspected urinary tract infection, antibiotic treatment, imaging for structural abnormalities such as vesicoureteral reflux, and evaluation and treatment of bowel and bladder dysfunction. It presents two strong recommendations and six conditional recommendations. The stated certainty of evidence for these recommendations ranges from low to very low, meaning that important uncertainty remains about some of the underlying evidence.
Who this may apply to
The guidance is intended for pediatric clinicians caring for children from 8 days through 5 years of age who have low medical complexity, across various settings. It may not directly apply to older children, newborns younger than 8 days, or children with substantial medical complexity. The abstract does not establish how each recommendation applies to every clinical situation, and the low to very low certainty of much of the evidence means that the strength of individual guidance varies.
Why it matters
Urinary tract infections are common bacterial infections in infants and young children, and fever can be associated with these infections. This guideline may help clinicians interpret the available evidence across diagnosis and management decisions. Its relevance is tempered by the limited certainty assigned to the individual recommendations and by the fact that guidelines summarize evidence rather than generate new clinical outcomes.
Limitations & evidence assessment
The abstract provides no details about the number of studies included, the number of children represented in the underlying research, or the specific results supporting each recommendation. The guideline itself reports low to very low certainty for its eight key clinical recommendations, which limits confidence in those recommendations. As a guideline and evidence review, it does not provide a new randomized comparison or a direct estimate of outcomes for a newly enrolled patient group. Its intended population is also limited to children with low medical complexity, so applicability to children with more complex medical conditions is not established from the abstract.
Why this evidence level: Clinical guideline / consensus statement reflecting reviewed bodies of evidence.
Evidence levels are editorial estimates derived from study metadata — they are not clinical appraisals.
// Source
PEDIATRICS · 2026 · DOI: 10.1542/peds.2026-078565
Authors: Brian K. Alverson, David S. Hains, Stephen M. Downs, Rana E. El Feghaly, Catherine S. Forster, Shabnam Jain, Andrea Johnston, Tej K. Mattoo, Caleb P. Nelson, Olusoji Olakanpo, Hansel J. Otero, Craig A. Peters, Nicole M. Poppinga, Dipanwita Saha, Alan R. Schroeder, Emily Senerth, Lauren Pilcher, Susan K. Flinn, Rebecca L. Morgan, Reem A. Mustafa
Institutions: University of Pittsburgh, Johns Hopkins University, Wayne State University, Children's Hospital of Philadelphia, Children's Healthcare of Atlanta, Emory University, Case Western Reserve University, Indiana University School of Medicine, Stanford University, Stanford Medicine, Children's Mercy Hospital, McMaster University, The University of Texas Southwestern Medical Center, University of Missouri–Kansas City, Kaiser Permanente, University of Kansas Medical Center, Boston Children's Hospital, Wake Forest University, American Academy of Pediatrics, University of South Dakota, Avera McKennan Hospital & University Health Center, Mount Sinai Hospital, The University of Kansas Health System, Wake Forest University Health Sciences


